Long-Read Sequencing and Structural Variant Detection: Unlocking the Hidden Genome in Rare Genetic Disorders
Authors:
- Efthalia MoustakliEMEfthalia Moustakli
- Panagiotis ChristopoulosPanagiotis Christopoulos
- Anastasios PotirisAnastasios Potiris
- Athanasios ZikopoulosAZAthanasios Zikopoulos
- Despoina MavrogianniDMDespoina Mavrogianni
- Grigorios KarampasGKGrigorios Karampas
- Nikolaos KathopoulisNikolaos Kathopoulis
- Ismini AnagnostakiIAIsmini Anagnostaki
- Ekaterini DomaliEDEkaterini Domali
- Alexandros T. TzallasAlexandros T. Tzallas
- Peter DrakakisPDPeter Drakakis
- Sofoklis StavrosSSSofoklis Stavros
Top Cited Papers
Open Access
- 17 July 2025
- journal article
- review article
- Published by MDPI AG in Diagnostics
- Vol. 15 (14) , 1803
Abstract
Rare genetic diseases are often caused by structural variants (SVs), such as insertions, deletions, duplications, inversions, and complex rearrangements. However, due to the technical limitations of short-read sequencing, these variants remain underdiagnosed. Long-read sequencing technologies, including Oxford Nanopore and Pacific Biosciences high-fidelity (HiFi), have recently advanced to the point that they can accurately find SVs throughout the genome, including in previously unreachable areas like repetitive sequences and segmental duplications. This study underscores the transformative role of long-read sequencing in diagnosing rare diseases, emphasizing the bioinformatics tools designed for detecting and interpreting structural variants (SVs). Comprehensive methods are reviewed, including methylation profiling, RNA-seq, phasing analysis, and long-read sequencing. The effectiveness and applications of well-known tools like Sniffles2, SVIM, and cuteSV are also assessed. Case studies illustrate how this technique has revealed new pathogenic pathways and solved cases that were previously undetected. Along with outlining potential future paths like telomere-to-telomere assemblies and pan-genome integration, we also address existing issues, including cost, clinical validation, and computational complexity. For uncommon genetic illnesses, long-read sequencing has the potential to completely change the molecular diagnostic picture as it approaches clinical adoption.Keywords
This publication has 83 references indexed in Scilit:
- Variants of uncertain significance: At the crux of diagnostic odysseyGene, 2025
- A meta-analysis of diagnostic yield and clinical utility of genome and exome sequencing in pediatric rare and undiagnosed genetic diseasesGenetics in Medicine, 2025
- Targeted Long‐Read Sequencing as a Single Assay Improves the Diagnosis of Spastic‐Ataxia DisordersAnnals of Clinical and Translational Neurology, 2025
- Advancing long-read nanopore genome assembly and accurate variant calling for rare disease detectionThe American Journal of Human Genetics, 2025
- Nanopore sequencing: flourishing in its teenage yearsJournal of Genetics and Genomics, 2024
- Applications of genome sequencing as a single platform for clinical constitutional genetic testingGenetics in Medicine Open, 2024
- Long‐read sequencing for molecular diagnostics in constitutional genetic disordersHuman Mutation, 2022
- StrVCTVRE: A supervised learning method to predict the pathogenicity of human genome structural variantsThe American Journal of Human Genetics, 2022
- Rare Genetic Diseases: Nature's Experiments on Human DevelopmentiScience, 2020
- Comparison of Exome and Genome Sequencing Technologies for the Complete Capture of Protein‐Coding RegionsHuman Mutation, 2015